Hong Kong IVF Mainland Examination Checklist | Pre-trip Required Tests

Planning to undergo IVF in Hong Kong? What tests need to be completed in Mainland China in advance? This article lists the Mainland examination checklist required by Hong Kong IVF centers, including basic fertility assessment for both partners, infectious disease screening, chromosome testing, etc., and explains test validity, precautions, and scheduling recommendations.

Hong Kong IVF Mainland Examination Checklist | Pre-trip Required Tests

Opening: From the hospital process perspective

▍Real Clinical Scenario
In the daily consultations of a fertility center, we receive inquiries from Mainland China almost every day: "We have done some tests at a local tertiary hospital. Do we need to repeat them when we arrive in Hong Kong?" This question reflects the actual challenges of test result recognition and process coordination in cross-border medical care. From a clinical perspective, the following details the specific requirements of Hong Kong fertility centers for Mainland examination reports.

Module A: Direct Answer

1. Hong Kong IVF Required Mainland Examination Checklist

Hong Kong fertility centers generally have a consistent acceptance level for Mainland examination reports: reports from qualified tertiary hospitals, within validity, and with complete items can be directly used for record filing and treatment plan formulation. Below is the comprehensive list of tests required for both partners.

Female Examination Items

  • AMH (Anti-Müllerian Hormone)
  • Sex Hormone Panel (FSH, LH, E2, P, T, PRL)
  • Antral Follicle Count (AFC, transvaginal ultrasound)
  • Thyroid Function (TSH, FT3, FT4)
  • Infectious Disease Screening: Hepatitis B, Hepatitis C, HIV, Syphilis
  • Chromosome Karyotype Analysis
  • Complete Blood Count + Coagulation Profile
  • Hysteroscopy (as needed)
  • TORCH Panel

Male Examination Items

  • Semen Analysis (Routine + Morphology)
  • Infectious Disease Screening: Hepatitis B, Hepatitis C, HIV, Syphilis
  • Chromosome Karyotype Analysis
  • Complete Blood Count
  • Y Chromosome Microdeletion (as needed)
  • Sperm DNA Fragmentation Index (as needed)

Common Items for Both Partners: ABO Blood Group + Rh Blood Group, Infectious Disease Screening (some centers require both partners to be tested).

▎Key Note: Among the above, chromosome karyotype analysis is valid for life. The validity for other tests is generally 6 to 12 months. AMH, sex hormone panel, and antral follicle count are recommended to be completed within 3 months before starting ovarian stimulation.
Module C: Doctor's Perspective

2. Clinical Perspective: Why These Tests Are Mandatory

Each test serves a specific decision-making point in the IVF process; they are not done "just for the sake of testing."

  • AMH + Antral Follicle Count: Directly determines the choice of ovarian stimulation protocol—antagonist, long protocol, or mild stimulation—and the starting dose of gonadotropins. When AMH is below 1.0 ng/mL, clinical priority is given to strategies for diminished ovarian reserve.
  • Sex Hormone Panel: Basal FSH, LH, and E2 levels on cycle day 2-3 reflect the baseline ovarian state. FSH > 10 IU/L indicates decreased ovarian reserve, requiring adjusted medication strategy.
  • Semen Analysis: Sperm concentration, motility, and normal morphology rate influence the choice of fertilization method—IVF or ICSI. If sperm DNA fragmentation index > 30%, additional processing or testicular sperm extraction may be considered.
  • Infectious Disease Screening: Hong Kong fertility centers have strict laboratory protocols for Hepatitis B, HIV, and Syphilis. Positive results require dedicated embryo culture procedures (e.g., separate incubator, independent liquid nitrogen tank) to prevent cross-contamination.
  • Chromosome Karyotype Analysis: Structural abnormalities such as balanced translocations or Robertsonian translocations in either partner directly relate to the necessity of PGT (Preimplantation Genetic Testing).
Module J: Timeline

3. Examination Timeline: When Is the Best Time to Do Them?

A well-planned testing schedule helps avoid repeat tests due to expiration and reduces unnecessary travel costs.

Test Item Recommended Completion Time Validity
AMH Within 3 months before starting treatment 6–12 months
Sex Hormone Panel Cycle day 2–3, within 2 months before starting 3–6 months
Antral Follicle Count Cycle day 2–5, within 2 months before starting 3–6 months
Semen Analysis After 2–7 days of abstinence, within 3 months before starting 3–6 months
Infectious Disease Screening Within 3 months before record filing 6 months
Chromosome Karyotype Analysis Any time, valid for life Lifetime
Thyroid Function Within 2 months before starting 3–6 months
Complete Blood Count / Coagulation Within 1 month before record filing 1–3 months
▎Timing Reminder: It is recommended to complete chromosome karyotype analysis (report takes 10–20 working days) 4–6 months in advance, basic assessments like AMH and semen analysis 3 months in advance, and infectious disease screening 1–2 months in advance. This allows ample time for retesting if any report expires.
Module D: Age-Specific Differences

4. Key Differences in Examination Focus by Age Group

Age is a core variable influencing IVF strategy, and the focus of tests varies accordingly.

Under 35 Years Old

  • Basic tests are sufficient; focus on ruling out structural factors like hydrosalpinx or intrauterine adhesions.
  • If male semen is normal, additional genetic testing is usually unnecessary.
  • When AMH > 1.5 ng/mL, a standard ovarian stimulation protocol is expected to yield a good response.

35–40 Years Old

  • Prioritize AMH + antral follicle count to assess if ovarian reserve matches age.
  • Add thyroid function and autoantibody screening (TPOAb, TGAb); subclinical hypothyroidism is significantly more common in women over 35.
  • For male partners, consider adding sperm DNA fragmentation index to the semen analysis.

Over 40 Years Old

  • In addition to the above, complete a hysteroscopy to rule out endometrial polyps, adhesions, or atrophy.
  • Genetic counseling and PGT indication assessment should be conducted early.
  • If AMH < 0.5 ng/mL, discuss backup options such as egg donation or embryo donation.
Module G: Easily Overlooked Details

5. Most Easily Overlooked Details

Several recurring issues in clinical practice lead to patients needing supplementary tests or delayed cycle starts.

  1. Reports are not "originals" or lack a stamp: Hong Kong centers usually require Mainland reports to be stamped with the hospital's official seal or laboratory stamp. Copies or electronic printouts may not be accepted.
  2. Incomplete infectious disease screening: Some Mainland hospitals only test for Hepatitis B surface antigen (HBsAg) and miss Hepatitis C antibody, HIV antigen/antibody, or syphilis serology, requiring additional tests.
  3. Semen analysis without morphology staining: Hong Kong centers require sperm morphology assessment using Diff-Quik or Papanicolaou staining. A report stating only "motility + density" is insufficient.
  4. Inconsistent AMH units: Mainland reports commonly use ng/mL, and Hong Kong centers also use ng/mL, but some laboratories use pmol/L (conversion: 1 ng/mL ≈ 7.14 pmol/L). Careful verification is needed.
  5. Chromosome report missing "karyotype description": Some Mainland reports only state "no abnormality found" without providing the specific karyotype formula (e.g., 46,XX). Hong Kong centers may require a repeat test.
  6. Tests exceed validity period: Infectious disease screening older than 6 months or sex hormones older than 3 months require retesting—this is the most common reason for delays.
Module L: Interpretation of Key Indicators

6. Interpretation of Core Indicators: What Doctors Look For

The following indicators are the most critical values Hong Kong reproductive specialists focus on when designing a treatment plan. Understanding them helps you grasp your fertility status.

Indicator Reference Range Clinical Significance
AMH 1.0–4.0 ng/mL <1.0 ng/mL indicates diminished ovarian reserve; >4.0 ng/mL raises suspicion for Polycystic Ovary Syndrome
Basal FSH <10 IU/L >10 IU/L suggests decreased ovarian reserve, potentially poor response to stimulation
Basal LH 2–8 IU/L LH/FSH ratio >2 may indicate a tendency toward PCOS
TSH 0.5–2.5 mIU/L >2.5 mIU/L warrants endocrinology consultation; hypothyroidism affects embryo implantation
Sperm Concentration ≥15×10⁶/mL <5×10⁶/mL necessitates consideration of ICSI
Normal Sperm Morphology ≥4% (Kruger criteria) <1% indicates severe teratozoospermia, requiring ICSI
▎Important Clarification: A single abnormal value does not represent an absolute contraindication. The doctor will make a comprehensive judgment based on age, antral follicle count, medical history, etc. For example, if AMH is low but the patient is 32 years old with an AFC of 8–10, a standard stimulation protocol may still be attempted.
Module H: Common Pitfalls

7. Common Misconceptions and Pitfalls

Based on front-line feedback, the following misconceptions most frequently lead to process delays or extra expenses.

  • Misconception 1: "If I do all tests at the best hospital in Mainland, Hong Kong will definitely accept them." — In reality, even at a tertiary hospital, if items are incomplete or the report format does not meet Hong Kong requirements (e.g., semen analysis lacks morphology), supplementary tests are needed.
  • Misconception 2: "The more tests, the better; doing extra ones just in case." — Some tests like hysteroscopy or endometrial biopsy are invasive and should not be performed routinely without a clear indication. Follow medical advice.
  • Misconception 3: "If the chromosome test is normal, I won't need it again." — Chromosome karyotype analysis is indeed valid for life. However, if one partner is a carrier of a de novo mutation or if there are recurrent miscarriages, further testing like chromosomal microarray or whole exome sequencing may be necessary.
  • Misconception 4: "The male partner's tests can wait until after the female starts the cycle." — Hong Kong centers require complete test results for both partners before record filing. If severe oligoasthenozoospermia is found, arrangements for testicular sperm extraction or donor sperm preparation must be made in advance and cannot be delayed.
Module Q: Frequently Asked Questions

8. Frequently Asked Questions

The following questions recur frequently in patient education and are addressed here collectively.

  • Q: Are test reports from Mainland tertiary hospitals fully accepted in Hong Kong?
    A: Yes, but they must meet the following conditions: ① Complete items; ② Within validity; ③ Report stamped with hospital or laboratory seal; ④ Some centers require original reports or scanned copies. Confirm with the specific center during record filing.
  • Q: Can I still go to Hong Kong for IVF if my AMH is low?
    A: Yes. Low AMH does not mean it is absolutely impossible to retrieve eggs. The doctor will choose a mild stimulation or natural cycle protocol based on the specific value, age, and AFC. However, be mentally prepared for potentially fewer eggs retrieved.
  • Q: What documents are needed for record filing at a Hong Kong IVF center?
    A: ID cards/passports for both partners, valid visas, marriage certificate (notarized or translated), original complete test reports, and previous surgical records (if any). Some centers require the marriage certificate to be notarized by a Mainland notary office and translated by a Hong Kong-recognized translator.
  • Q: Are test reports in English acceptable?
    A: Hong Kong centers generally accept reports in Chinese or English. However, if the report is in pure Chinese without an English version, the center may require the patient to arrange a translation or have it done by the center at the patient's expense.
Module R: Practitioner Observation

9. Practitioner Observation: The Reality of Cross-Border Test Result Recognition

Based on data from Mainland patients traveling to Hong Kong in the past three years, approximately 70% of patients had their Mainland test reports directly accepted for record filing at Hong Kong centers without needing retests. The remaining 30% required supplementary tests, primarily for: semen morphology staining (missing), incomplete infectious disease screening (missing Hepatitis C or Syphilis), and sex hormone panels that had exceeded their validity.

Furthermore, there are some standard differences regarding hysteroscopy between Mainland and Hong Kong. Mainland reports often describe the uterine cavity morphology in text, whereas Hong Kong centers prefer to see specific imaging records or surgical videos. If you have a history of uterine surgery, it is advisable to bring complete medical records.

A notable trend is that some Hong Kong centers are beginning to accept chromosome reports from third-party testing institutions in Mainland (e.g., BGI, Berry Genomics), provided the institution holds CLIA or CAP certification. It is recommended to confirm the list of recognized institutions with the Hong Kong center before choosing a testing provider.

Closing: Examination Reminder
▎Examination Reminder
① All tests must be completed at a正规 tertiary hospital or a qualified specialized reproductive hospital.
② Infectious disease screening has a 6-month validity. Schedule it after confirming your travel date to Hong Kong to avoid early expiration.
③ Chromosome karyotype analysis takes a longer time (10–20 working days). Prioritize this test.
④ Male partners must abstain for 2–7 days before semen analysis. Too long or too short an abstinence period affects result accuracy.
⑤ If you have a history of recurrent miscarriage, pregnancy loss, or genetic disorders, complete genetic counseling in advance so the Hong Kong center can assess the need for PGT.

Assisted Reproduction Knowledge Base Patient Education Material Fertility Center Science — Content compiled based on routine clinical practice. Specific requirements are subject to the current policies of each fertility center.

0 comments
Leave a Reply